Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-057924
Filing Date
2021-04-30
Accepted
2021-04-29 19:48:14
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm212622d3_defa14a.htm DEFA14A 15463
2 GRAPHIC tm212622d3_defa14aimg001.jpg GRAPHIC 149684
3 GRAPHIC tm212622d3_defa14aimg002.jpg GRAPHIC 92835
4 GRAPHIC tm212622d3_defa14aimg003.jpg GRAPHIC 16152
  Complete submission text file 0001104659-21-057924.txt   373097
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38905 | Film No.: 21873054
SIC: 2834 Pharmaceutical Preparations